Browse by UCL people
Group by: Type | Date
Number of items: 52.
Article
Anderton, J;
Moroz, V;
Marec-Bérard, P;
Gaspar, N;
Laurence, V;
Martín-Broto, J;
Sastre, A;
... Brennan, B; + view all
(2020)
International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol.
Trials
, 21
(1)
, Article 96. 10.1186/s13063-019-4026-8.
|
 |
|
Bielack, SS;
Smeland, S;
Whelan, J;
Marina, N;
Hook, J;
Jovic, G;
Krailo, MD;
... Bernstein, ML; + view all
(2013)
MAP plus maintenance pegylated interferon alpha-2b (MAP-IFN) versus MAP alone in patients (pts) with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomization.
Journal of Clinical Oncology
, 31
(15)
10.1200/JCO.2014.60.0734.
|
 |
|
Bogaerts, J;
Sydes, MR;
Keat, N;
McConnell, A;
Benson, A;
Ho, A;
Roth, A;
... Seymour, M; + view all
(2015)
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative.
Eur J Cancer
, 51
(3)
pp. 271-281.
10.1016/j.ejca.2014.10.027.
|
|
Brennan, B;
Kirton, L;
Marec-Bérard, P;
Gaspar, N;
Laurence, V;
Martín-Broto, J;
Sastre, A;
... Wheatley, K; + view all
(2022)
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
The Lancet
, 400
(10362)
pp. 1513-1521.
10.1016/S0140-6736(22)01790-1.
|
|
Budde, Axel;
Baust, Katja;
Weinhold, Leonie;
Bernstein, Mark;
Bielack, Stefan;
Dhooge, Catharina;
Hjorth, Lars;
... Schmid, Matthias; + view all
(2022)
Erratum to 'Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma' [Eur J Cancer 170 (2022) 209-235].
European Journal of Cancer
, 177
pp. 208-209.
10.1016/j.ejca.2022.06.053.
|
|
Calaminus, G;
Jenney, M;
Hjorth, L;
Baust, K;
Bernstein, M;
Bielack, S;
Vos, PD;
... Nagarajan, R; + view all
(2019)
Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy.
JMIR Research Protocols
, 8
(9)
, Article e14406. 10.2196/14406.
|
|
|
Carter, TJ;
Milic, M;
McDerra, J;
McTiernan, A;
Ahmed, M;
Karavasilis, V;
Michelagnoli, M;
... Strauss, SJ; + view all
(2020)
Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis.
Cancers
, 12
(11)
, Article 3408. 10.3390/cancers12113408.
|
|
|
Casali, PG;
Bielack, S;
Abecassis, N;
Aro, HT;
Bauer, S;
Biagini, R;
Bonvalot, S;
... Blay, JY; + view all
(2018)
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology
, 29
(4)
pp. 79-95.
10.1093/annonc/mdy310.
|
|
|
Chugh, R;
Ballman, KV;
Helman, LJ;
Patel, S;
Whelan, JS;
Widemann, B;
Lu, Y;
... Strauss, SJ; + view all
(2020)
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
Cancer
10.1002/cncr.33349.
|
|
|
Dangoor, A;
Seddon, B;
Gerrand, C;
Grimer, R;
Whelan, J;
Judson, I;
(2016)
UK guidelines for the management of soft tissue sarcomas.
Clinical Sarcoma Research
, 6
, Article 20. 10.1186/s13569-016-0060-4.
|
|
|
Dhinsa, BS;
DeLisa, M;
Pollock, R;
Flanagan, AM;
Whelan, J;
Gregory, J;
(2018)
Dedifferentiated Chondrosarcoma Demonstrating Osteosarcomatous Differentiation.
Oncology Research and Treatment
, 41
(7-8)
pp. 456-460.
10.1159/000487803.
|
|
|
Fern, LA;
Taylor, RM;
Barber, J;
Alvarez-Galvez, J;
Feltbower, R;
Lea, S;
Martins, A;
... Whelan, J; + view all
(2021)
Processes of care and survival associated with treatment in specialist teenage and young adult cancer centres: results from the BRIGHTLIGHT cohort study.
BMJ Open
, 11
(4)
, Article e044854. 10.1136/bmjopen-2020-044854.
|
|
|
Fresneau, B;
Hackshaw, A;
Hawkins, DS;
Paulussen, M;
Anderson, JR;
Judson, I;
Litiere, S;
... Le Teuff, G; + view all
(2017)
Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study).
Pediatric Blood & Cancer
, 64
(8)
, Article e26457. 10.1002/pbc.26457.
|
|
|
Frezza, AM;
Beale, T;
Bomanji, J;
Jay, A;
Kalavrezos, N;
Dileo, P;
Whelan, J;
(2014)
Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
BMC Cancer
, 14
, Article 23. 10.1186/1471-2407-14-23.
|
|
|
Gerrand, C;
Bate, J;
Seddon, B;
Dirksen, U;
Randall, RL;
van de Sande, M;
O'Donnell, P;
... Whelan, J; + view all
(2020)
Seeking international consensus on approaches to primary tumour treatment in Ewing sarcoma.
Clinical Sarcoma Research
, 10
, Article 21. 10.1186/s13569-020-00144-6.
|
|
|
Henderson, SR;
Guiliano, D;
Presneau, N;
McLean, S;
Frow, R;
Vujovic, S;
Anderson, J;
... Boshoff, C; + view all
(2005)
A molecular map of mesenchymal tumors.
GENOME BIOL
, 6
(9)
, Article R76. 10.1186/gb-2005-6-9-r76.
|
|
|
Henson, KE;
Reulen, RC;
Winter, DL;
Bright, CJ;
Fidler, MM;
Frobisher, C;
Guha, J;
... Hawkins, MM; + view all
(2016)
Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.
Circulation
, 134
(20)
pp. 1519-1531.
10.1161/CIRCULATIONAHA.116.022514.
|
|
Hughes, L;
Fern, LA;
Whelan, JS;
Taylor, RM;
Study Group, B;
(2023)
Young people's opinions of cancer care in England: the BRIGHTLIGHT cohort.
BMJ open
, 13
(9)
, Article e069910. 10.1136/bmjopen-2022-069910.
|
|
|
Ingley, KM;
Maleddu, A;
Le Grange, F;
Gerrand, C;
Bleyer, A;
Yasmin, E;
Whelan, J;
(2022)
Current approaches to management of bone sarcoma in adolescent and young adult patients.
Pediatric Blood & Cancer
, 69
(2)
, Article e29442. 10.1002/pbc.29442.
|
|
Kenten, C;
Martins, A;
Fern, LA;
Gibson, F;
Lea, S;
Ngwenya, N;
Whelan, JS;
(2017)
Qualitative study to understand the barriers to recruiting young people with cancer to BRIGHTLIGHT: a national cohort study in England.
BMJ Open
, 7
(11)
, Article e018291. 10.1136/bmjopen-2017-018291.
|
|
|
Kenten, C;
Ngwenya, N;
Gibson, F;
Flatley, M;
Jones, L;
Pearce, S;
Wong, G;
... Whelan, J; + view all
(2019)
Understanding care when cure is not likely for young adults who face cancer: a realist analysis of data from patients, families and healthcare professionals.
BMJ Open
, 9
(1)
, Article e024397. 10.1136/bmjopen-2018-024397.
|
|
|
Koo, MM;
Lyratzopoulos, G;
Herbert, A;
Abel, GA;
Taylor, RM;
Barber, JA;
Gibson, F;
... Fern, LA; + view all
(2020)
Association of Self-reported Presenting Symptoms With Timeliness
of Help-Seeking Among Adolescents and Young Adults With Cancer
in the BRIGHTLIGHT Study.
JAMA Network Open
, 3
(9)
, Article e2015437. 10.1001/jamanetworkopen.2020.15437.
|
|
|
Lancia, C;
Anninga, J;
Spitoni, C;
Sydes, MR;
Whelan, J;
Hogendoorn, PCW;
Gelderblom, H;
(2019)
Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma.
BMJ Open
, 9
(5)
, Article e022980. 10.1136/bmjopen-2018-022980.
|
|
|
Lancia, C;
Anninga, JK;
Sydes, M;
Spitoni, C;
Whelan, J;
Hogendoorn, PCW;
Gelderblom, H;
(2019)
A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup.
Cancer Chemotherapy and Pharmacology
, 83
pp. 951-962.
10.1007/s00280-019-03797-3.
|
|
|
Lancia, C;
Spitoni, C;
Anninga, J;
Sydes, MR;
Jovic, G;
Fiocco, M;
(2018)
Marginal Structural Models with Dose-Delay Joint-Exposure for Assessing Variations to Chemotherapy Intensity.
Statistical Methods in Medical Research
10.1177/0962280218780619.
(In press).
|
|
|
Lyratzopoulos, G;
Herbert, A;
Whelan, J;
Taylor, RM;
Barber, J;
Gibson, F;
Fern, L;
(2018)
Diagnostic timeliness in teenagers and young adults with cancer: Cross-sectional findings from the BRIGHTLIGHT cohort.
The Lancet Child and Adolescent Health
, 2
(3)
pp. 180-190.
10.1016/S2352-4642(18)30004-X.
|
|
Marina, NM;
Smeland, S;
Bielack, SS;
Bernstein, M;
Jovic, G;
Krailo, MD;
Hook, JM;
... Whelan, JS; + view all
(2016)
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
The Lancet Oncology
, 17
(10)
pp. 1396-1408.
10.1016/S1470-2045(16)30214-5.
|
|
|
Martins, A;
Taylor, RM;
Lobel, B;
McCann, B;
Soanes, L;
Whelan, JS;
Fern, LA;
(2018)
Sex, Body Image, and Relationships: A BRIGHTLIGHT Workshop on Information and Support Needs of Adolescents and Young Adults.
Journal of Adolescent and Young Adult Oncology
, 7
(5)
pp. 572-578.
10.1089/jayao.2018.0025.
|
|
|
McTiernan, A;
Jinks, RC;
Sydes, MR;
Uscinska, B;
Hook, JM;
van Glabbeke, M;
Bramwell, V;
... Whelan, JS; + view all
(2012)
Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.
European Journal of Cancer
, 48
(5)
703 - 712.
10.1016/j.ejca.2011.09.012.
|
|
|
Ngwenya, N;
Kenten, C;
Jones, L;
Gibson, F;
Pearce, S;
Flatley, M;
Hough, R;
... Whelan, J; + view all
(2017)
Experiences and Preferences for End-of-Life Care for Young Adults with Cancer and Their Informal Carers: A Narrative Synthesis.
Journal of Adolescent and Young Adult Oncology
, 6
(2)
pp. 200-212.
10.1089/jayao.2016.0055.
|
|
|
Peneder, P;
Stutz, AM;
Surdez, D;
Krumbholz, M;
Semper, S;
Chicard, M;
Sheffield, NC;
... Tomazou, EM; + view all
(2021)
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.
Nature Communications
, 12
(1)
, Article 3230. 10.1038/s41467-021-23445-w.
|
|
|
Rothermundt, C;
Seddon, BM;
Dileo, P;
Strauss, SJ;
Coleman, J;
Briggs, TW;
Haile, SR;
(2016)
Follow-up practices for high-grade extremity Osteosarcoma.
BMC Cancer
, 16
, Article 301. 10.1186/s12885-016-2333-y.
|
|
|
Rothermundt, C;
Whelan, JS;
Dileo, P;
Strauss, SJ;
Coleman, J;
Briggs, TW;
Haile, SR;
(2014)
What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients.
British Journal of Cancer
, 110
(10)
pp. 2420-2426.
10.1038/bjc.2014.200.
|
|
|
Seddon, B;
Strauss, SJ;
Whelan, J;
Leahy, M;
Woll, PJ;
Cowie, F;
Rothermundt, C;
... Beare, S; + view all
(2017)
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
The Lancet Oncology
, 18
(10)
pp. 1397-1410.
10.1016/S1470-2045(17)30622-8.
|
|
Smeland, S;
Ingleby, F;
Many other authors, TPUTP;
Whelan, J;
Sydes, MR;
(2019)
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 cohort.
European Journal of Cancer
, 109
pp. 36-50.
10.1016/j.ejca.2018.11.027.
|
|
|
Strauss, SJ;
Anninga, J;
Baglio, R;
Baumhoer, D;
Behjati, S;
Bielack, S;
Boye, K;
... Whelan, J; + view all
(2018)
Report from the 4th European Bone Sarcoma Networking meeting: focus on osteosarcoma.
Clinical Sarcoma Research
, 8
, Article 17. 10.1186/s13569-018-0103-0.
|
|
|
Strauss, SJ;
Whelan, JS;
(2018)
Current questions in bone sarcomas.
Current Opinion in Oncology
, 30
(4)
pp. 252-259.
10.1097/CCO.0000000000000456.
|
|
Taylor, Rachel M;
Whelan, Jeremy S;
Barber, Julie A;
Alvarez-Galvez, Javier;
Feltbower, Richard G;
Gibson, Faith;
Stark, Dan P;
(2024)
The Impact of Specialist Care on Teenage and Young Adult Patient-Reported Outcomes in England: A BRIGHTLIGHT Study.
Journal of Adolescent and Young Adult Oncology
10.1089/jayao.2023.0141.
(In press).
|
|
|
Taylor, RM;
Fern, LA;
Barber, J;
Gibson, F;
Lea, S;
Patel, N;
Morris, S;
... Whelan, JS; + view all
(2021)
Specialist cancer services for teenagers and young adults in England: BRIGHTLIGHT research programme.
Programme Grants for Applied Research
, 9
(12)
10.3310/pgfar09120.
|
|
|
Taylor, RM;
Whelan, JS;
Gibson, F;
Morgan, S;
Fern, LA;
(2018)
Involving young people in BRIGHTLIGHT from study inception to secondary data analysis: Insights from 10 years of user involvement.
Research Involvement and Engagement
, 4
(1)
, Article 50. 10.1186/s40900-018-0135-x.
|
|
|
Taylor, RM;
Aslam, N;
Lea, S;
Whelan, JS;
Fern, LA;
(2017)
Optimizing a Retention Strategy with Young People for BRIGHTLIGHT, a Longitudinal Cohort Study Examining the Value of Specialist Cancer Care for Young People.
Journal of Adolescent and Young Adult Oncology
, 6
(3)
pp. 459-469.
10.1089/jayao.2016.0085.
|
 |
|
Taylor, RM;
Fern, LA;
Aslam, N;
Whelan, JS;
(2016)
Direct access to potential research participants for a cohort study using a confidentiality waiver included in UK National Health Service legal statutes.
BMJ Open
, 6
(8)
, Article e011847. 10.1136/bmjopen-2016-011847.
|
|
|
Taylor, RM;
Fern, LA;
Barber, J;
Alvarez-Galvez, J;
Feltbower, R;
Lea, S;
Martins, A;
... Whelan, J; + view all
(2020)
Longitudinal cohort study of the impact of specialist cancer services for teenagers and young adults on quality of life: outcomes from the BRIGHTLIGHT study.
BMJ Open
, 10
(11)
, Article e038471. 10.1136/bmjopen-2020-038471.
|
|
|
Taylor, RM;
Fern, LA;
Barber, J;
Alvarez-Galvez, J;
Feltbower, R;
Morris, S;
Hooker, L;
... Whelan, JS; + view all
(2019)
Description of the BRIGHTLIGHT cohort: the evaluation of teenage and young adult cancer services in England.
BMJ Open
, 9
(4)
, Article e027797. 10.1136/bmjopen-2018-027797.
|
|
|
Taylor, RM;
Fern, LA;
Solanki, A;
Hooker, L;
Carluccio, A;
Pye, J;
Jeans, D;
... Whelan, JS; + view all
(2015)
Development and validation of the BRIGHTLIGHT Survey, a patient-reported experience measure for young people with cancer.
Health and Quality of Life Outcomes
, 13
, Article 107. 10.1186/s12955-015-0312-7.
|
|
|
Taylor, RM;
Solanki, A;
Aslam, N;
Whelan, JS;
Fern, LA;
(2016)
A participatory study of teenagers and young adults views on access and participation in cancer research.
European Journal of Oncology Nursing
, 20
pp. 156-164.
10.1016/j.ejon.2015.07.007.
|
|
|
Vassiliou, LV;
Lalabekyan, B;
Jay, A;
Liew, C;
Whelan, J;
Newman, L;
Kalavrezos, N;
(2016)
Head and neck sarcomas: A single institute series.
Oral Oncology
, 65
pp. 16-22.
10.1016/j.oraloncology.2016.12.005.
|
|
Vindrola-Padros, C;
Taylor, RM;
Lea, S;
Hooker, L;
Pearce, S;
Whelan, J;
Gibson, F;
(2016)
Mapping Adolescent Cancer Services: How Do Young People, Their Families, and Staff Describe Specialized Cancer Care in England?
Cancer Nursing
, 39
(5)
pp. 358-366.
10.1097/NCC.0000000000000315.
|
|
Whelan, J;
Hackshaw, A;
McTiernan, A;
Grimer, R;
Spooner, D;
Bate, J;
Ranft, A;
... Lewis, I; + view all
(2018)
Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92.
Clinical Sarcoma Research
, 8
, Article 6. 10.1186/s13569-018-0093-y.
|
|
|
Whelan, JS;
Bielack, SS;
Marina, N;
Smeland, S;
Jovic, G;
Hook, JM;
Krailo, M;
... on behalf of the EURAMOS collaborators; + view all
(2014)
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Annals of Oncology
10.1093/annonc/mdu526.
|
|
|
Windsor, Rachael;
Hamilton, Anthony;
McTiernan, Anne;
Dileo, Palma;
Michelagnoli, Maria;
Seddon, Beatrice;
Strauss, Sandra J;
(2022)
Survival after high-dose chemotherapy for refractory and recurrent Ewing sarcoma.
European Journal of Cancer
, 170
pp. 131-139.
10.1016/j.ejca.2022.04.007.
|
Thesis
|
Whelan, J;
(2003)
Studies on cellular sensitivity and resistance to cytosine arabinoside.
UNSPECIFIED thesis , UNSPECIFIED.
|
